<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Generate Biomedicines, Inc. (GENB) on GreekSoup</title>
<link>https://greeksoup.ai/stocks/us/genb/</link>
<description>Every dated entry in the public record on Generate Biomedicines, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days.</description>
<language>en</language>
<atom:link href="https://greeksoup.ai/stocks/us/genb/feed.xml" rel="self" type="application/rss+xml"/>
<lastBuildDate>Sat, 31 Oct 2026 00:00:00 +0000</lastBuildDate>
<item><title>Generate Biomedicines, Inc.: Form 144, ARNOLD FRANCES plans to sell 11,409 shares worth $184,733 around 29 October 2026</title><link>https://greeksoup.ai/stocks/us/genb/planned-sales/</link><guid isPermaLink="false">us:GENB:planned-sale:2026-10-29:4a67fe09cb</guid><pubDate>Thu, 29 Oct 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000195917326007553/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: short interest 8,930,609 shares at the 15 October 2026 settlement, 7.99 days to cover</title><link>https://greeksoup.ai/stocks/us/genb/short-interest/</link><guid isPermaLink="false">us:GENB:short-interest:2026-10-15:b6408b05d9</guid><pubDate>Thu, 15 Oct 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: short interest 7,417,094 shares at the 30 September 2026 settlement, 5.75 days to cover</title><link>https://greeksoup.ai/stocks/us/genb/short-interest/</link><guid isPermaLink="false">us:GENB:short-interest:2026-09-30:add107a2c2</guid><pubDate>Wed, 30 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: short interest 7,180,013 shares at the 15 September 2026 settlement, 7.24 days to cover</title><link>https://greeksoup.ai/stocks/us/genb/short-interest/</link><guid isPermaLink="false">us:GENB:short-interest:2026-09-15:bfc33086e6</guid><pubDate>Tue, 15 Sep 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: Arnold Frances (Director) sold 1,000 shares (under a trading plan set in advance) at $16.00 on 1 September 2026, $16,002</title><link>https://greeksoup.ai/stocks/us/genb/insiders/</link><guid isPermaLink="false">us:GENB:insider:2026-09-03:f345e772e3</guid><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><category>Insider trade</category><description><![CDATA[<p>Insider trade. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000119312526381875/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/insiders/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: Form 144, ARNOLD FRANCES plans to sell 32,210 shares worth $520,631 around 2 September 2026</title><link>https://greeksoup.ai/stocks/us/genb/planned-sales/</link><guid isPermaLink="false">us:GENB:planned-sale:2026-09-02:369fd91817</guid><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000195917326006666/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: Form 144, ARNOLD FRANCES plans to sell 1,000 shares worth $16,002 around 1 September 2026</title><link>https://greeksoup.ai/stocks/us/genb/planned-sales/</link><guid isPermaLink="false">us:GENB:planned-sale:2026-09-01:0e596f12de</guid><pubDate>Tue, 01 Sep 2026 00:00:00 +0000</pubDate><category>Form 144</category><description><![CDATA[<p>Form 144. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000195917326006611/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/planned-sales/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: short interest 7,456,033 shares at the 31 August 2026 settlement, 3.74 days to cover</title><link>https://greeksoup.ai/stocks/us/genb/short-interest/</link><guid isPermaLink="false">us:GENB:short-interest:2026-08-31:2e6e4d2db4</guid><pubDate>Mon, 31 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc. filed 8-K: regulation fd disclosure</title><link>https://greeksoup.ai/stocks/us/genb/filings/</link><guid isPermaLink="false">us:GENB:filing:2026-08-26:b1520ab44b</guid><pubDate>Wed, 26 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000119312526365556/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc.: short interest 7,286,295 shares at the 14 August 2026 settlement, 15.09 days to cover</title><link>https://greeksoup.ai/stocks/us/genb/short-interest/</link><guid isPermaLink="false">us:GENB:short-interest:2026-08-14:2d98bda6c1</guid><pubDate>Fri, 14 Aug 2026 00:00:00 +0000</pubDate><category>Short interest</category><description><![CDATA[<p>Short interest. <a href="https://www.finra.org/finra-data/browse-catalog/equity-short-interest/data">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/short-interest/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc. Q2 FY2025 results: revenue $10 million, net income -$52 million</title><link>https://greeksoup.ai/stocks/us/genb/results/fy2025-q2/</link><guid isPermaLink="false">us:GENB:result:2026-08-06:759626c714</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0002100782&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/results/fy2025-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc. Q2 FY2026 results: revenue $6 million, net income -$67 million</title><link>https://greeksoup.ai/stocks/us/genb/results/fy2026-q2/</link><guid isPermaLink="false">us:GENB:result:2026-08-06:fbd94d3603</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>Results</category><description><![CDATA[<p>Results. <a href="https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&amp;CIK=0002100782&amp;type=10-&amp;dateb=&amp;owner=include&amp;count=40">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/results/fy2026-q2/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc. filed 8-K: results of operations</title><link>https://greeksoup.ai/stocks/us/genb/filings/</link><guid isPermaLink="false">us:GENB:filing:2026-08-06:1073ce4f8d</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000119312526336462/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
<item><title>Generate Biomedicines, Inc. filed 10-Q: 10-q</title><link>https://greeksoup.ai/stocks/us/genb/filings/</link><guid isPermaLink="false">us:GENB:filing:2026-08-06:10710b3b1d</guid><pubDate>Thu, 06 Aug 2026 00:00:00 +0000</pubDate><category>SEC filing</category><description><![CDATA[<p>SEC filing. <a href="https://www.sec.gov/Archives/edgar/data/2100782/000119312526336437/">The filing</a>. <a href="https://greeksoup.ai/stocks/us/genb/filings/">The page on GreekSoup</a>.</p>]]></description></item>
</channel>
</rss>
